Wednesday, 21 Aug 2019

You are here

RheumNow Week in Review – 22 April 2016

Highlights from this week on RheumNow.com

  1. Systematic review by Felson et al shows that MTX use in current RA clinical trials is suboptimal, most using 15mg, the highest dose was 20mg/wk and only one trial with parenteral MTX.  https://t.co/1DYHxLK2DJ
  2. There's a despirate need for effective DMARD or biologic therapy for patients with with erosive osteoarthritis! GSK announced the launch of its Phase 2 trial of GM-CSF MAb in patients with inflammatory hand OA. https://t.co/cXNdTDufR7
  3. Celltrion chief executive said that Inflectra is expected to be priced ~20-30% lower than Remicade when released in the US. https://t.co/ceCHuYubzK
  4. Perioperative MTX use does not cause increased postoperative infectious complications or sepsis in IBD patients having abdominal surgery. https://t.co/ApgCyEhpeG
  5. A New Look at Old Pictures.  Dr. David Pisetsky blogs on the appropriate or misleading use of picture to educate. 
  6. Do's and Don'ts of Vaccination: a (Very) Brief Guide for Rheumatologists by Dr. Kevin Winthrop.  
  7. Vaccine Success is Limited in Rheumatoid Arthritis.  
  8. α Defensin Control of Inflammation.  The protective effects of defensins and their therapeutic potential is proposed.  
  9. BeST Trial and 10-Year Outcomes of Four Treatment Strategies
  10. Osteoporotic Fractures at Higher Risk for Subsequent Fractures  

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – Antibiotics Increase RA Risk (8.16.19)

Dr. Jack Cush reports the news and important journal articles from the past week on RheumNow.com.

RheumNow Podcast – Tricked Up Lupus Criteria (8.9.19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including new SLE criteria, ULT in gout and MSU reductions, IVIG in ANCA vasculitis and non-TNF biologics outperform the TNF inhibitors.

EULAR Recommendations on Large Vessel Vasculitis

Th European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) was originally published in 2009. Since then there have been new randomised clinical trials and cohort analyses leading to an update the original recommendations.

RheumNow Podcast – More Than a Spot of Tea (8.2.19)

Dr. Jack Cush reviews the journal articles and news reports from the past week on RheumNow.com: MMP-7 and Myositis-ILD; Post-surgical gout attacks; CV events and testosterone; and a Boxed warning for tofacitinib.

RheumNow Podcast – FDA Hyperactivity (7.26.19)

Dr. Jack Cush reviews the news, journal reports, and FDA releases and deliberations covered this past week on RheumNow.com